Correlation Between MannKind Corp and Larimar Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MannKind Corp and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MannKind Corp and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MannKind Corp and Larimar Therapeutics, you can compare the effects of market volatilities on MannKind Corp and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MannKind Corp with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MannKind Corp and Larimar Therapeutics.

Diversification Opportunities for MannKind Corp and Larimar Therapeutics

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between MannKind and Larimar is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding MannKind Corp and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and MannKind Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MannKind Corp are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of MannKind Corp i.e., MannKind Corp and Larimar Therapeutics go up and down completely randomly.

Pair Corralation between MannKind Corp and Larimar Therapeutics

Given the investment horizon of 90 days MannKind Corp is expected to generate 1.24 times less return on investment than Larimar Therapeutics. But when comparing it to its historical volatility, MannKind Corp is 1.9 times less risky than Larimar Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  340.00  in Larimar Therapeutics on August 24, 2024 and sell it today you would earn a total of  273.00  from holding Larimar Therapeutics or generate 80.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MannKind Corp  vs.  Larimar Therapeutics

 Performance 
       Timeline  
MannKind Corp 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, MannKind Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.
Larimar Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

MannKind Corp and Larimar Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MannKind Corp and Larimar Therapeutics

The main advantage of trading using opposite MannKind Corp and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MannKind Corp position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.
The idea behind MannKind Corp and Larimar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal